Related Experiment Video
Updated: Sep 1, 2025

03:55
Author Spotlight: FISH as a Tool for Precise Gene Amplification Assessment in Cancer Specimens
Published on: July 12, 2024
1.5K
Extrachromosomal DNA amplifications in cancer
Eunhee Yi1, Rocío Chamorro González2,3,4, Anton G Henssen5,6,7,8,9
1The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Nature Reviews. Genetics
|August 11, 2022
Summary
Extrachromosomal DNA (ecDNA) amplification drives cancer by altering gene expression and promoting cell diversity. Understanding ecDNA
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Extrachromosomal DNA (ecDNA) amplification is a frequent driver of cancer, linked to poor patient prognosis.
- ecDNA's circular structure influences chromatin, epigenetics, and heterogeneous copy number during cell division.
Purpose of the Study:
- To review the generation of ecDNA.
- To explore the genetic and epigenetic architecture of ecDNA.
- To discuss ecDNA's role in proto-oncogene deregulation and its therapeutic potential.
Main Methods:
- Literature review and synthesis of current research on ecDNA.
- Analysis of ecDNA's structural complexity, localization, and functional mechanisms.
- Examination of ecDNA's impact on oncogenesis and potential as therapeutic targets.
Main Results:
- ecDNA exhibits complex structures, localizes to nuclear hubs, and can function as an enhancer.
- ecDNA's unique properties contribute to proto-oncogene amplification and deregulation.
- Recent findings highlight ecDNA's role in driving cancer and its potential as a therapeutic vulnerability.
Conclusions:
- ecDNA generation and architecture are critical in cancer development.
- Targeting ecDNA's unique functions presents novel therapeutic opportunities in oncology.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
12.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.5K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Induced Pluripotent Stem Cells
4.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.3K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Non-LTR Retrotransposons
11.8K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.8K

